These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

187 related items for PubMed ID: 12110614

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Development of a selective photoactivatable antagonist for corticotropin-releasing factor receptor, type 2 (CRF2).
    Bonk I, Rühmann A.
    Eur J Biochem; 2002 Nov; 269(21):5288-94. PubMed ID: 12392562
    [Abstract] [Full Text] [Related]

  • 6. Structural requirements for peptidic antagonists of the corticotropin-releasing factor receptor (CRFR): development of CRFR2beta-selective antisauvagine-30.
    Rühmann A, Bonk I, Lin CR, Rosenfeld MG, Spiess J.
    Proc Natl Acad Sci U S A; 1998 Dec 22; 95(26):15264-9. PubMed ID: 9860957
    [Abstract] [Full Text] [Related]

  • 7. Evidence for the abundant expression of arginine 185 containing human CRF(2alpha) receptors and the role of position 185 for receptor-ligand selectivity.
    Dautzenberg FM, Huber G, Higelin J, Py-Lang G, Kilpatrick GJ.
    Neuropharmacology; 2000 Jun 08; 39(8):1368-76. PubMed ID: 10818253
    [Abstract] [Full Text] [Related]

  • 8. Comparison of an agonist, urocortin, and an antagonist, astressin, as radioligands for characterization of corticotropin-releasing factor receptors.
    Perrin MH, Sutton SW, Cervini LA, Rivier JE, Vale WW.
    J Pharmacol Exp Ther; 1999 Feb 08; 288(2):729-34. PubMed ID: 9918582
    [Abstract] [Full Text] [Related]

  • 9. Potent and long-acting corticotropin releasing factor (CRF) receptor 2 selective peptide competitive antagonists.
    Rivier J, Gulyas J, Kirby D, Low W, Perrin MH, Kunitake K, DiGruccio M, Vaughan J, Reubi JC, Waser B, Koerber SC, Martinez V, Wang L, Taché Y, Vale W.
    J Med Chem; 2002 Oct 10; 45(21):4737-47. PubMed ID: 12361401
    [Abstract] [Full Text] [Related]

  • 10. 125I-Antisauvagine-30: a novel and specific high-affinity radioligand for the characterization of corticotropin-releasing factor type 2 receptors.
    Higelin J, Py-Lang G, Paternoster C, Ellis GJ, Patel A, Dautzenberg FM.
    Neuropharmacology; 2001 Oct 10; 40(1):114-22. PubMed ID: 11077077
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Pharmacological characterization of a novel nonpeptide antagonist radioligand, (+/-)-N-[2-methyl-4-methoxyphenyl]-1-(1-(methoxymethyl) propyl)-6-methyl-1H-1,2,3-triazolo[4,5-c]pyridin-4-amine ([3H]SN003) for corticotropin-releasing factor1 receptors.
    Zhang G, Huang N, Li YW, Qi X, Marshall AP, Yan XX, Hill G, Rominger C, Prakash SR, Bakthavatchalam R, Rominger DH, Gilligan PJ, Zaczek R.
    J Pharmacol Exp Ther; 2003 Apr 10; 305(1):57-69. PubMed ID: 12649353
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Cortagine, a specific agonist of corticotropin-releasing factor receptor subtype 1, is anxiogenic and antidepressive in the mouse model.
    Tezval H, Jahn O, Todorovic C, Sasse A, Eckart K, Spiess J.
    Proc Natl Acad Sci U S A; 2004 Jun 22; 101(25):9468-73. PubMed ID: 15192151
    [Abstract] [Full Text] [Related]

  • 17. Ligand requirements of the human corticotropin-releasing factor-binding protein.
    Sutton SW, Behan DP, Lahrichi SL, Kaiser R, Corrigan A, Lowry P, Potter E, Perrin MH, Rivier J, Vale WW.
    Endocrinology; 1995 Mar 22; 136(3):1097-102. PubMed ID: 7867564
    [Abstract] [Full Text] [Related]

  • 18. Corticotropin-releasing factor receptors induce calcium mobilization through cross-talk with Gq-coupled receptors.
    Gutknecht E, Vauquelin G, Dautzenberg FM.
    Eur J Pharmacol; 2010 Sep 10; 642(1-3):1-9. PubMed ID: 20594969
    [Abstract] [Full Text] [Related]

  • 19. The alternatively spliced type II corticotropin-releasing factor receptor, stably expressed in LLCPK-1 cells, is not well coupled to the G protein(s).
    Nabhan C, Xiong Y, Xie LY, Abou-Samra AB.
    Biochem Biophys Res Commun; 1995 Jul 26; 212(3):1015-21. PubMed ID: 7626087
    [Abstract] [Full Text] [Related]

  • 20. Differential actions of peripheral corticotropin-releasing factor (CRF), urocortin II, and urocortin III on gastric emptying and colonic transit in mice: role of CRF receptor subtypes 1 and 2.
    Martínez V, Wang L, Rivier JE, Vale W, Taché Y.
    J Pharmacol Exp Ther; 2002 May 26; 301(2):611-7. PubMed ID: 11961064
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.